Envista Holdings Corp (NYSE:NVST)
$ 27.38 -1.25 (-4.37%) Market Cap: 4.46 Bil Enterprise Value: 4.96 Bil PE Ratio: 47.21 PB Ratio: 1.45 GF Score: 79/100

Q2 2026 Envista Holdings Corp Earnings Call Transcript

Aug 05, 2026 / 09:00PM GMT
Release Date Price: $28.63 (+2.40%)

Key Points

Positve
  • Envista Holdings Corp (NVST) delivered strong Q2 2026 results with 5% core growth, leading to a 28% increase in adjusted EBITDA and a 58% increase in adjusted EPS.
  • The company raised its full-year 2026 guidance for core growth (3.5%-4.5%), adjusted EBITDA growth (11%-14%), and adjusted EPS ($1.50-$1.55) due to strong first-half performance.
  • Growth was broad-based, with both reporting segments (Specialty Products & Technologies and Equipment & Consumables) and all major geographies (North America, Europe, APAC, Latin America) contributing positively.
  • The Equipment & Consumables segment delivered strong 8.5% core growth, driven by high single-digit growth in both consumables and diagnostics, with the company gaining market share in these areas.
  • The Spark clear aligner business continued its momentum with double-digit growth, and new product launches (Denseal Probe, DemiPro, ODB expansion) are expected to further drive share gains.
  • Operational excellence initiatives led to significant margin expansion, with adjusted gross margin up 70 basis points and adjusted EBITDA margin up 230 basis points year-over-year.
  • The company generated strong free cash flow of $105 million in Q2, with a conversion rate of 158%, and continues to return capital to shareholders through share repurchases.
  • Management successfully reduced the effective tax rate to 25% in Q2 and now expects a full-year rate of ~26%, which is 2 points lower than initial guidance.
  • The company's balance sheet remains strong with net debt to adjusted EBITDA of 0.7 times, providing flexibility for future investments and M&A.
  • New product innovation is playing a central role in growth, with recent launches like the S-Series implant system and the Versa acquisition performing ahead of plan.
Negative
  • The company expects a significant slowdown in Q4 2026 core growth to flat or slightly down due to a calendar impact of four fewer selling days, which will also temper adjusted EBITDA growth in the second half.
  • The Brackets & Wires business experienced a high single-digit decline in Q2, impacted by a strong prior year comp that benefited from customers buying ahead of announced tariffs and price activity.
  • The upcoming China Volume-Based Procurement (VBP) for orthodontics (VBP1) and implants (VBP2) is expected to create headwinds, with significant price compression anticipated in the second half of 2026.
  • The company's implants business only grew low single-digits, which is in line with the market but reflects ongoing macro uncertainty impacting more elective dental procedures.
  • Tariff costs increased by $5 million year-over-year in Q2, and while currently offset, the company expects similar tariff costs in the second half, with new Section 301 levies replacing prior tariffs.
  • The company is increasing investments in sales, marketing, and R&D, which amounted to an $11 million headwind to adjusted EBITDA in Q2, and these investments are expected to continue in the second half.
  • Foreign exchange rates are expected to have a near-zero impact on sales in the second half of 2026, removing a tailwind that contributed $11 million to Q2 revenue growth.
  • The company's guidance implies a step-down in underlying growth in the second half of 2026 to approximately 3.5% core growth, even after normalizing for selling days and the Spark deferral benefit.
  • The China VBP process is expected to result in a neutral price contribution for the company in the second half, as price declines in China offset strong price capture in other regions.
  • The company faces uncertainty regarding the volume response to the China VBP price cuts, particularly for orthodontics, where it is more difficult to expand supply and train clinicians.
Operator

Hello, my name is Chloe and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Invista Holdings Corporation's second quarter 2026 earnings results conference call. (Operator Instructions) I will now turn the call over to Mr. Jim Gustafson, Vice President of Investor Relations at InVista Holdings. Mr. Gustafson, you may begin your conference.

Jim Gustafson Envista Holdings Corp;Vice President of Investor Relations

Good afternoon. Thanks for joining Invista's second-quarter 2026 earnings call. We appreciate your interest in our company. With me today are Paul Keel, our President and Chief Executive Officer and Eric Hammes, our Chief Financial Officer.

Before I begin, I want to point out that our earnings release, the slide presentation supplementing today's call and the reconciliations and other information required by SEC Regulation G relating to any non-GAAP financial measures provided during the call are available on the Investors section of our website,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot